John Grange

Director at Immodulon Therapeutics Limited - London, England, United Kingdom

John Grange's Colleagues at Immodulon Therapeutics Limited
John Grange's Contact Details
HQ
(973) 671-1615
Location
London,England,United Kingdom
Company
Immodulon Therapeutics Limited
John Grange's Company Details
Immodulon Therapeutics Limited logo, Immodulon Therapeutics Limited contact details

Immodulon Therapeutics Limited

London, England, United Kingdom • 9 Employees
Biotechnology

IMMODULON, LEADERS IN IMMUNO-ONCOLOGYImmodulon Therapeutics Ltd. is a privately-owned clinical-stage immuno-oncology company primarily focused on the development of safe, effective and novel treatments for cancer. Its lead drug candidate, IMM-101, has shown promise in early clinical trials, demonstrating potential for the platform. IMM-101 has a unique mechanism of action that should not only make this innovative product applicable to a large range of cancers but, in combination with immune checkpoint inhibitors and other standard-of-care treatments, is expected to enhance their efficacy without increasing the safety burden for the patient.

Details about Immodulon Therapeutics Limited
Frequently Asked Questions about John Grange
John Grange currently works for Immodulon Therapeutics Limited.
John Grange's role at Immodulon Therapeutics Limited is Director.
John Grange's email address is ***@immodulon.com. To view John Grange's full email address, please signup to ConnectPlex.
John Grange works in the Biotechnology industry.
John Grange's colleagues at Immodulon Therapeutics Limited are and others.
John Grange's phone number is (973) 671-1615
See more information about John Grange